Rifaximin description

Revision as of 20:54, 9 January 2014 by Chetan Lokhande (talk | contribs) (Created page with "__NOTOC__ {{Rifaximin}} {{CMG}}; {{AE}} {{chetan}} http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5e8e2fd-7087-4b78-9181-cc259c0be2f1 ==References== {{Reflist}} ...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Rifaximin
XIFAXAN® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]


http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5e8e2fd-7087-4b78-9181-cc259c0be2f1


References

Adapted from the FDA Package Insert.

Retrieved from "https://www.wikidoc.org/index.php?title=Rifaximin_description&oldid=930745"